This report aims to provide a comprehensive presentation of the global market for TCR-T Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TCR-T Therapy. This report contains market size and forecasts of TCR-T Therapy in global, including the following market information:
Global TCR-T Therapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global TCR-T Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Autologous Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of TCR-T Therapy include Athenex, Xiangxue Pharmaceutical (Xiangxue Precision), Hengrui Yuanzheng, Eureka Therapeutics, WuXi Juno, Shenzhen Inno Immunity, Shenzhen Binde Bio and Kerui Bio, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the TCR-T Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global TCR-T Therapy Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global TCR-T Therapy Market Segment Percentages, by Type, 2022 (%)
Autologous
Allogeneic
Global TCR-T Therapy Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global TCR-T Therapy Market Segment Percentages, by Application, 2022 (%)
Refractory Relapsed Melanoma
Synovial Sarcoma
Multiple Myeloma
Lung Cancer
Other
Global TCR-T Therapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global TCR-T Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies TCR-T Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies TCR-T Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Athenex
Xiangxue Pharmaceutical (Xiangxue Precision)
Hengrui Yuanzheng
Eureka Therapeutics
WuXi Juno
Shenzhen Inno Immunity
Shenzhen Binde Bio
Kerui Bio
Outline of Major Chapters:
Chapter 1: Introduces the definition of TCR-T Therapy, market overview.
Chapter 2: Global TCR-T Therapy market size in revenue.
Chapter 3: Detailed analysis of TCR-T Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of TCR-T Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 TCR-T Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global TCR-T Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global TCR-T Therapy Overall Market Size
2.1 Global TCR-T Therapy Market Size: 2022 VS 2032
2.2 Global TCR-T Therapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top TCR-T Therapy Players in Global Market
3.2 Top Global TCR-T Therapy Companies Ranked by Revenue
3.3 Global TCR-T Therapy Revenue by Companies
3.4 Top 3 and Top 5 TCR-T Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies TCR-T Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 TCR-T Therapy Players in Global Market
3.6.1 List of Global Tier 1 TCR-T Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 TCR-T Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global TCR-T Therapy Market Size Markets, 2022 & 2032
4.1.2 Autologous
4.1.3 Allogeneic
4.2 By Type - Global TCR-T Therapy Revenue & Forecasts
4.2.1 By Type - Global TCR-T Therapy Revenue, 2018-2023
4.2.2 By Type - Global TCR-T Therapy Revenue, 2024-2032
4.2.3 By Type - Global TCR-T Therapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global TCR-T Therapy Market Size, 2022 & 2032
5.1.2 Refractory Relapsed Melanoma
5.1.3 Synovial Sarcoma
5.1.4 Multiple Myeloma
5.1.5 Lung Cancer
5.1.6 Other
5.2 By Application - Global TCR-T Therapy Revenue & Forecasts
5.2.1 By Application - Global TCR-T Therapy Revenue, 2018-2023
5.2.2 By Application - Global TCR-T Therapy Revenue, 2024-2032
5.2.3 By Application - Global TCR-T Therapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global TCR-T Therapy Market Size, 2022 & 2032
6.2 By Region - Global TCR-T Therapy Revenue & Forecasts
6.2.1 By Region - Global TCR-T Therapy Revenue, 2018-2023
6.2.2 By Region - Global TCR-T Therapy Revenue, 2024-2032
6.2.3 By Region - Global TCR-T Therapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America TCR-T Therapy Revenue, 2018-2032
6.3.2 US TCR-T Therapy Market Size, 2018-2032
6.3.3 Canada TCR-T Therapy Market Size, 2018-2032
6.3.4 Mexico TCR-T Therapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe TCR-T Therapy Revenue, 2018-2032
6.4.2 Germany TCR-T Therapy Market Size, 2018-2032
6.4.3 France TCR-T Therapy Market Size, 2018-2032
6.4.4 U.K. TCR-T Therapy Market Size, 2018-2032
6.4.5 Italy TCR-T Therapy Market Size, 2018-2032
6.4.6 Russia TCR-T Therapy Market Size, 2018-2032
6.4.7 Nordic Countries TCR-T Therapy Market Size, 2018-2032
6.4.8 Benelux TCR-T Therapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia TCR-T Therapy Revenue, 2018-2032
6.5.2 China TCR-T Therapy Market Size, 2018-2032
6.5.3 Japan TCR-T Therapy Market Size, 2018-2032
6.5.4 South Korea TCR-T Therapy Market Size, 2018-2032
6.5.5 Southeast Asia TCR-T Therapy Market Size, 2018-2032
6.5.6 India TCR-T Therapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America TCR-T Therapy Revenue, 2018-2032
6.6.2 Brazil TCR-T Therapy Market Size, 2018-2032
6.6.3 Argentina TCR-T Therapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa TCR-T Therapy Revenue, 2018-2032
6.7.2 Turkey TCR-T Therapy Market Size, 2018-2032
6.7.3 Israel TCR-T Therapy Market Size, 2018-2032
6.7.4 Saudi Arabia TCR-T Therapy Market Size, 2018-2032
6.7.5 UAE TCR-T Therapy Market Size, 2018-2032
7 TCR-T Therapy Companies Profiles
7.1 Athenex
7.1.1 Athenex Company Summary
7.1.2 Athenex Business Overview
7.1.3 Athenex TCR-T Therapy Major Product Offerings
7.1.4 Athenex TCR-T Therapy Revenue in Global Market (2018-2023)
7.1.5 Athenex Key News & Latest Developments
7.2 Xiangxue Pharmaceutical (Xiangxue Precision)
7.2.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Summary
7.2.2 Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
7.2.3 Xiangxue Pharmaceutical (Xiangxue Precision) TCR-T Therapy Major Product Offerings
7.2.4 Xiangxue Pharmaceutical (Xiangxue Precision) TCR-T Therapy Revenue in Global Market (2018-2023)
7.2.5 Xiangxue Pharmaceutical (Xiangxue Precision) Key News & Latest Developments
7.3 Hengrui Yuanzheng
7.3.1 Hengrui Yuanzheng Company Summary
7.3.2 Hengrui Yuanzheng Business Overview
7.3.3 Hengrui Yuanzheng TCR-T Therapy Major Product Offerings
7.3.4 Hengrui Yuanzheng TCR-T Therapy Revenue in Global Market (2018-2023)
7.3.5 Hengrui Yuanzheng Key News & Latest Developments
7.4 Eureka Therapeutics
7.4.1 Eureka Therapeutics Company Summary
7.4.2 Eureka Therapeutics Business Overview
7.4.3 Eureka Therapeutics TCR-T Therapy Major Product Offerings
7.4.4 Eureka Therapeutics TCR-T Therapy Revenue in Global Market (2018-2023)
7.4.5 Eureka Therapeutics Key News & Latest Developments
7.5 WuXi Juno
7.5.1 WuXi Juno Company Summary
7.5.2 WuXi Juno Business Overview
7.5.3 WuXi Juno TCR-T Therapy Major Product Offerings
7.5.4 WuXi Juno TCR-T Therapy Revenue in Global Market (2018-2023)
7.5.5 WuXi Juno Key News & Latest Developments
7.6 Shenzhen Inno Immunity
7.6.1 Shenzhen Inno Immunity Company Summary
7.6.2 Shenzhen Inno Immunity Business Overview
7.6.3 Shenzhen Inno Immunity TCR-T Therapy Major Product Offerings
7.6.4 Shenzhen Inno Immunity TCR-T Therapy Revenue in Global Market (2018-2023)
7.6.5 Shenzhen Inno Immunity Key News & Latest Developments
7.7 Shenzhen Binde Bio
7.7.1 Shenzhen Binde Bio Company Summary
7.7.2 Shenzhen Binde Bio Business Overview
7.7.3 Shenzhen Binde Bio TCR-T Therapy Major Product Offerings
7.7.4 Shenzhen Binde Bio TCR-T Therapy Revenue in Global Market (2018-2023)
7.7.5 Shenzhen Binde Bio Key News & Latest Developments
7.8 Kerui Bio
7.8.1 Kerui Bio Company Summary
7.8.2 Kerui Bio Business Overview
7.8.3 Kerui Bio TCR-T Therapy Major Product Offerings
7.8.4 Kerui Bio TCR-T Therapy Revenue in Global Market (2018-2023)
7.8.5 Kerui Bio Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. TCR-T Therapy Market Opportunities & Trends in Global Market
Table 2. TCR-T Therapy Market Drivers in Global Market
Table 3. TCR-T Therapy Market Restraints in Global Market
Table 4. Key Players of TCR-T Therapy in Global Market
Table 5. Top TCR-T Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global TCR-T Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global TCR-T Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies TCR-T Therapy Product Type
Table 9. List of Global Tier 1 TCR-T Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 TCR-T Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global TCR-T Therapy Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - TCR-T Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - TCR-T Therapy Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global TCR-T Therapy Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - TCR-T Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - TCR-T Therapy Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global TCR-T Therapy Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global TCR-T Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global TCR-T Therapy Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America TCR-T Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America TCR-T Therapy Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe TCR-T Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe TCR-T Therapy Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia TCR-T Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia TCR-T Therapy Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America TCR-T Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America TCR-T Therapy Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa TCR-T Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa TCR-T Therapy Revenue, (US$, Mn), 2024-2032
Table 30. Athenex Company Summary
Table 31. Athenex TCR-T Therapy Product Offerings
Table 32. Athenex TCR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Athenex Key News & Latest Developments
Table 34. Xiangxue Pharmaceutical (Xiangxue Precision) Company Summary
Table 35. Xiangxue Pharmaceutical (Xiangxue Precision) TCR-T Therapy Product Offerings
Table 36. Xiangxue Pharmaceutical (Xiangxue Precision) TCR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Xiangxue Pharmaceutical (Xiangxue Precision) Key News & Latest Developments
Table 38. Hengrui Yuanzheng Company Summary
Table 39. Hengrui Yuanzheng TCR-T Therapy Product Offerings
Table 40. Hengrui Yuanzheng TCR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Hengrui Yuanzheng Key News & Latest Developments
Table 42. Eureka Therapeutics Company Summary
Table 43. Eureka Therapeutics TCR-T Therapy Product Offerings
Table 44. Eureka Therapeutics TCR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Eureka Therapeutics Key News & Latest Developments
Table 46. WuXi Juno Company Summary
Table 47. WuXi Juno TCR-T Therapy Product Offerings
Table 48. WuXi Juno TCR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. WuXi Juno Key News & Latest Developments
Table 50. Shenzhen Inno Immunity Company Summary
Table 51. Shenzhen Inno Immunity TCR-T Therapy Product Offerings
Table 52. Shenzhen Inno Immunity TCR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Shenzhen Inno Immunity Key News & Latest Developments
Table 54. Shenzhen Binde Bio Company Summary
Table 55. Shenzhen Binde Bio TCR-T Therapy Product Offerings
Table 56. Shenzhen Binde Bio TCR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Shenzhen Binde Bio Key News & Latest Developments
Table 58. Kerui Bio Company Summary
Table 59. Kerui Bio TCR-T Therapy Product Offerings
Table 60. Kerui Bio TCR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Kerui Bio Key News & Latest Developments
List of Figures
Figure 1. TCR-T Therapy Segment by Type in 2022
Figure 2. TCR-T Therapy Segment by Application in 2022
Figure 3. Global TCR-T Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global TCR-T Therapy Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global TCR-T Therapy Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by TCR-T Therapy Revenue in 2022
Figure 8. By Type - Global TCR-T Therapy Revenue Market Share, 2018-2032
Figure 9. By Application - Global TCR-T Therapy Revenue Market Share, 2018-2032
Figure 10. By Type - Global TCR-T Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global TCR-T Therapy Revenue Market Share, 2018-2032
Figure 12. By Application - Global TCR-T Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global TCR-T Therapy Revenue Market Share, 2018-2032
Figure 14. By Region - Global TCR-T Therapy Revenue Market Share, 2018-2032
Figure 15. By Country - North America TCR-T Therapy Revenue Market Share, 2018-2032
Figure 16. US TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 17. Canada TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe TCR-T Therapy Revenue Market Share, 2018-2032
Figure 20. Germany TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 21. France TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 23. Italy TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 24. Russia TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia TCR-T Therapy Revenue Market Share, 2018-2032
Figure 28. China TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 29. Japan TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 32. India TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America TCR-T Therapy Revenue Market Share, 2018-2032
Figure 34. Brazil TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa TCR-T Therapy Revenue Market Share, 2018-2032
Figure 37. Turkey TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 38. Israel TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 40. UAE TCR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 41. Athenex TCR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Xiangxue Pharmaceutical (Xiangxue Precision) TCR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Hengrui Yuanzheng TCR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Eureka Therapeutics TCR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. WuXi Juno TCR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Shenzhen Inno Immunity TCR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Shenzhen Binde Bio TCR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Kerui Bio TCR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
